HGH Fragment 176-191: research, legal status and who sells it
This page is information, not medical advice. HGH Fragment 176-191 is not approved as a medicine in the markets below unless stated. We don't publish dosing or usage instructions.
- Also known as
- hGH 176-191, Human growth hormone fragment 176-191, HGH Frag 176-191
- Category
- Synthetic peptide matching amino acids 176-191 of human growth hormone
- Evidence level
- Preclinical (lab and animal studies)
- Price range
- $2.80/mg to $22.39/mg, median $8.99/mg across 15 vendors (compare)
- Our lab tests
- None yet (how testing will work)
Legal and regulatory status
| Where | Status |
|---|---|
| United States | No FDA-approved drug contains hGH fragment 176-191 [1]. |
| United Kingdom | No UK-licensed medicine containing hGH fragment 176-191 appears in the MHRA products database [2]. |
| European Union | No medicine containing hGH fragment 176-191 is authorized in the EU, according to EMA's central and Article 57 product data [3][4]. |
| Canada | No product containing hGH fragment 176-191 appears in Health Canada's Drug Product Database [5]. |
| Australia | hGH fragment 176-191 is not named in Australia's Poisons Standard (October 2026), which names the related growth hormone fragment AOD-9604 in Schedule 4 with Appendix D possession controls [6]. |
| Sport (WADA) | Named as a prohibited growth hormone fragment (hGH 176-191) under S2 [7]. |
We haven't published a full overview of HGH Fragment 176-191 yet. The legal status table and live prices on this page are current.
HGH Fragment 176-191 prices: cheapest listings
The five lowest $/mg listings out of 18. See all HGH Fragment 176-191 prices
| Vendor | Transparency | Product | Size | Price | $/mg | Stock | Vendor's page |
|---|---|---|---|---|---|---|---|
| Chimera Peptides | 27 | 5 mg × 10 | $140 | $2.80/mg | View | ||
| Peptides Warehouse | 62 | 5 mg | $27 | $5.39/mg | View | ||
| Geo Peptides | 52 | Fragment 176-191 5mg (USA) | 5 mg | $28 | $5.60/mg | View | |
| Swiss Chems FDA warning letter, Dec 2024 | 72 | 5 mg | $38 | $7.67/mg | View | ||
| Premier Bio Labs | 72 | 5 mg | $39 | $7.80/mg | Out of stock | View |
Sources
- Drugs@FDA: FDA-Approved Drugs (database searched by active ingredient). U.S. Food and Drug Administration. Accessed Oct 15, 2026
- MHRA Products: licensed-medicine search for "hgh fragment 176-191". Medicines and Healthcare products Regulatory Agency (UK). Accessed Oct 15, 2026
- EMA medicines data: centrally authorised human medicines (export of 14 October 2026). European Medicines Agency. Accessed Oct 15, 2026
- EMA Article 57 product data: medicines authorised in the EU/EEA (data as of 9 October 2026). European Medicines Agency. Accessed Oct 15, 2026
- Drug Product Database online query (searched by active ingredient). Health Canada. Accessed Oct 15, 2026
- Therapeutic Goods (Poisons Standard—October 2026) Instrument 2026 (F2026L01327, registered 30 September 2026). Federal Register of Legislation, Australian Government. Accessed Oct 15, 2026
- World Anti-Doping Code International Standard: Prohibited List 2026 (in force 1 January 2026). World Anti-Doping Agency. Accessed Oct 15, 2026
- Human Growth Hormone Fragment 176-191 Peptide Enhances the Toxicity of Doxorubicin-Loaded Chitosan Nanoparticles Against MCF-7 Breast Cancer Cells. Drug Design, Development and Therapy (2022). Accessed Oct 15, 2026